Preclinical Development Handbook

[1]  D. Otzen,et al.  Structural background of cyclodextrin-protein interactions. , 2003, Protein engineering.

[2]  S. Harrison,et al.  Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor , 2005, Science.

[3]  N. Shibata,et al.  Absorption of interferon alpha from patches in rats , 2005, Journal of drug targeting.

[4]  E. J. Oliveira,et al.  Liquid chromatography-mass spectrometry in the study of the metabolism of drugs and other xenobiotics. , 2000, Biomedical chromatography : BMC.

[5]  Shaomeng Wang,et al.  Structure-based design, synthesis and biochemical testing of novel and potent Smac peptido-mimetics. , 2005, Bioorganic & medicinal chemistry letters.

[6]  Hans-Joachim Böhm,et al.  LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads , 1992, J. Comput. Aided Mol. Des..

[7]  K. Rossman,et al.  Crystal structure of Rac1 in complex with the guanine nucleotide exchange region of Tiam1 , 2000, Nature.

[8]  W. Naidong,et al.  Bioanalytical liquid chromatography tandem mass spectrometry methods on underivatized silica columns with aqueous/organic mobile phases. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  J. Rosenfeld.  Solid-phase analytical derivatization: enhancement of sensitivity and selectivity of analysis. , 1999, Journal of chromatography. A.

[10]  Xiaodong Wang,et al.  A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death , 2004, Science.

[11]  Q. Xu,et al.  Physical and chemical stability of gemcitabine hydrochloride solutions. , 1999, Journal of the American Pharmaceutical Association.

[12]  L. Vassilev,et al.  Targeting protein–protein interactions for cancer therapy , 2005, Journal of Molecular Medicine.

[13]  P. Perämäki,et al.  Development of analytical methods for the determination of sub-ppm concentrations of palladium and iron in methotrexate. , 2004, Journal of pharmaceutical and biomedical analysis.

[14]  M. Jemal.  High-throughput quantitative bioanalysis by LC/MS/MS. , 2000, Biomedical chromatography : BMC.

[15]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[16]  Michelle Arkin,et al.  Protein-protein interactions and cancer: small molecules going in for the kill. , 2005, Current opinion in chemical biology.

[17]  D. Mount.  Bioinformatics: Sequence and Genome Analysis , 2001 .

[18]  H. Nakazawa,et al.  Application of liquid chromatography-mass spectrometry to the quantification of bisphenol A in human semen. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[19]  R. Elgie.  A Fresh Look at Semipresidentialism: Variations on a Theme , 2005 .

[20]  Brian K. Shoichet,et al.  ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..

[21]  Jonathan M. Goodman,et al.  Chemical Applications of Molecular Modeling , 1998 .

[22]  J. Jasper.  The increasing use of stable isotopes in the pharmaceutical industry , 1999 .

[23]  A. Verkman.  Drug discovery in academia. , 2004, American journal of physiology. Cell physiology.

[24]  Michael P. Hall,et al.  Stable isotope methods for high-precision proteomics. , 2005, Drug discovery today.

[25]  J Mazziotta,et al.  A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[26]  Æleen Frisch,et al.  Exploring chemistry with electronic structure methods , 1996 .

[27]  S. Srinivasula,et al.  Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. di Iulio,et al.  Optimization of a pharmacophore model for 5-HT4 agonists using CoMFA and receptor based alignment. , 2006, European journal of medicinal chemistry.

[29]  M. Schulz,et al.  Ultrathin-layer chromatography. , 2002, Journal of chromatographic science.

[30]  A. Leo,et al.  Substituent constants for correlation analysis in chemistry and biology , 1979 .

[31]  Z. Ouyang,et al.  The Use of a Dual Dye Photometric Calibration Method to Identify Possible Sample Dilution from an Automated Multichannel Liquid-handling System , 2006 .

[32]  D. Louis Collins,et al.  Application of Information Technology: A Four-Dimensional Probabilistic Atlas of the Human Brain , 2001, J. Am. Medical Informatics Assoc..

[33]  E. Solon,et al.  Whole-body autoradiography in drug discovery. , 2002, Current drug metabolism.

[34]  S. Ebel.  Chromatographic Analysis of Pharmaceuticals, 2nd edition , 1997 .

[35]  Shaomeng Wang,et al.  Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonists. , 2003, Seminars in oncology.

[36]  Nenad Trinajstić,et al.  An algorithm for construction of the molecular distance matrix , 1987 .

[37]  Erik Nordling,et al.  Generalization of a targeted library design protocol: application to 5-HT7 receptor ligands. , 2004, Journal of chemical information and computer sciences.

[38]  Gisbert Schneider,et al.  Virtual screening and fast automated docking methods. , 2002, Drug discovery today.

[39]  Thilo Stehle,et al.  Crystal Structure of the Extracellular Segment of Integrin αVβ3 in Complex with an Arg-Gly-Asp Ligand , 2002, Science.

[40]  D. Dimitrov,et al.  The SARS-CoV S glycoprotein: expression and functional characterization , 2003, Biochemical and Biophysical Research Communications.

[41]  O. Ivanciuc,et al.  Comparative Receptor Surface Analysis (CoRSA) Model for Calcium Channel Antagonists , 2001, SAR and QSAR in environmental research.

[42]  A. Maritan,et al.  The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies. , 2002, Journal of molecular biology.

[43]  D. T. Rossi,et al.  Integrated sample collection and handling for drug discovery bioanalysis. , 2000, Journal of pharmaceutical and biomedical analysis.

[44]  W. Sponsel,et al.  Determination of voriconazole in aqueous humor by liquid chromatography-electrospray ionization-mass spectrometry. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[45]  R. Webster Homer,et al.  SYBYL Line Notation (SLN): A Versatile Language for Chemical Structure Representation , 1997, J. Chem. Inf. Comput. Sci..

[46]  Anthony Long,et al.  Computer systems for the prediction of xenobiotic metabolism. , 2002, Advanced drug delivery reviews.

[47]  Dipanwita Roy Chowdhury,et al.  Human protein reference database as a discovery resource for proteomics , 2004, Nucleic Acids Res..

[48]  Y. Guan,et al.  The severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[49]  D. Dalvie,et al.  Recent advances in the applications of radioisotopes in drug metabolism, toxicology and pharmacokinetics. , 2000, Current pharmaceutical design.

[50]  Shibo Jiang,et al.  Design of a protein surface antagonist based on alpha-helix mimicry: inhibition of gp41 assembly and viral fusion. , 2002, Angewandte Chemie.

[51]  G. M. Consoli,et al.  Designed calix[8]arene-based ligands for selective tryptase surface recognition. , 2004, Bioorganic & medicinal chemistry.

[52]  Jürgen Bajorath,et al.  Chemoinformatics : concepts, methods, and tools for drug discovery , 2004 .

[53]  J. Henion,et al.  High-throughput liquid chromatography-tandem mass spectrometry determination of bupropion and its metabolites in human, mouse and rat plasma using a monolithic column. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[54]  William J. Welsh,et al.  Enrichment of Ligands for the Serotonin Receptor Using the Shape Signatures Approach , 2005, J. Chem. Inf. Model..

[55]  N. Claude Cohen,et al.  Guidebook on molecular modeling in drug design , 1996 .

[56]  H. Nohta,et al.  Fluorogenic reactions for biomedical chromatography. , 1994, Journal of chromatography. B, Biomedical applications.

[57]  A. Hamilton,et al.  Catalytic unfolding and proteolysis of cytochrome C induced by synthetic binding agents. , 2004, Journal of the American Chemical Society.

[58]  K. Heinig,et al.  Application of column-switching liquid chromatography-tandem mass spectrometry for the determination of pharmaceutical compounds in tissue samples. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[59]  C. Hanson.  Healthcare Informatics , 2005 .

[60]  Timothy Clark,et al.  In Silico Prediction of Buffer Solubility Based on Quantum-Mechanical and HQSAR- and Topology-Based Descriptors , 2006, J. Chem. Inf. Model..

[61]  E. Coutinho,et al.  A CoMFA study of COX-2 inhibitors with receptor based alignment. , 2004, Journal of molecular graphics & modelling.

[62]  L. Hall,et al.  Molecular connectivity in chemistry and drug research , 1976 .

[63]  Stephen F. Betz,et al.  Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain , 2000, Nature.

[64]  V. Schurig.  Practice and theory of enantioselective complexation gas chromatography. , 2002, Journal of chromatography. A.

[65]  O. Lastra,et al.  Development and validation of an UV derivative spectrophotometric determination of Losartan potassium in tablets. , 2003, Journal of pharmaceutical and biomedical analysis.

[66]  Marie-Paule Lefranc,et al.  Ontology for immunogenetics: the IMGT-ONTOLOGY , 1999, Bioinform..

[67]  W Griffith Humphreys,et al.  Safety assessment of drug metabolites: Characterization of chemically stable metabolites. , 2006, Chemical research in toxicology.

[68]  Marie-Paule Lefranc,et al.  IMGT-ONTOLOGY for immunogenetics and immunoinformatics , 2003, Silico Biol..

[69]  J. Ermer,et al.  Applications of hyphenated LC-MS techniques in pharmaceutical analysis. , 2000, Biomedical chromatography : BMC.

[70]  Carlos G. Bell,et al.  LIQUID SCINTILLATION COUNTING , 1959 .

[71]  Vladimir Brusic,et al.  Bioinformatic strategies for better understanding of immune function , 2003, Silico Biol..

[72]  Gerd Folkers,et al.  Molecular Modeling, Basic Principles and Applications , 1996 .

[73]  D. Wu,et al.  Pharmacokinetics, mass balance, and tissue distribution of a novel DNA alkylating agent, VNP40101M, in rats , 2008, AAPS PharmSci.

[74]  E. Hahn‐Deinstrop.  Applied thin-layer chromatography , 2000 .

[75]  Yuan-Qing Xia,et al.  LC-MS Development strategies for quantitative bioanalysis. , 2006, Current drug metabolism.

[76]  S F Howard,et al.  Molecular characterization of the hdm2-p53 interaction. , 1997, Journal of molecular biology.

[77]  Rick Mullin.  TUFTS REPORT ANTICIPATES UPTURN: Cites drugmakers' actions to accelerate drug development , 2006 .

[78]  B. Matuszewski,et al.  Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. , 2003, Analytical chemistry.

[79]  I. Benhar.  Biotechnological applications of phage and cell display. , 2001, Biotechnology advances.

[80]  F. Tagliaro,et al.  Biomedical applications of capillary electrophoresis. , 1994, Journal of chromatography. B, Biomedical applications.

[81]  Markus A Lill,et al.  Novel ligands for the chemokine receptor-3 (CCR3): a receptor-modeling study based on 5D-QSAR. , 2005, Journal of medicinal chemistry.

[82]  J. Henion,et al.  Liquid-liquid extraction in the 96-well plate format with SRM LC/MS quantitative determination of methotrexate and its major metabolite in human plasma. , 1999, Analytical chemistry.

[83]  Wei Zhou,et al.  Direct injection of 96-well organic extracts onto a hydrophilic interaction chromatography/tandem mass spectrometry system using a silica stationary phase and an aqueous/organic mobile phase. , 2004, Rapid communications in mass spectrometry : RCM.

[84]  N. Srinivas,et al.  Gas chromatographic determination of enantiomers as diastereomers following pre-column derivatization and applications to pharmacokinetic studies: a review. , 1995, Biomedical chromatography : BMC.

[85]  Ich Step,et al.  ICH Q1E EVALUATION OF stability DATA , 2003 .

[86]  J. Gasteiger,et al.  Chemoinformatics: A Textbook , 2003 .

[87]  M. Pastor,et al.  A strategy for the incorporation of water molecules present in a ligand binding site into a three-dimensional quantitative structure--activity relationship analysis. , 1997, Journal of medicinal chemistry.

[88]  Richard S Larson,et al.  Design and structure of peptide and peptidomimetic antagonists of protein-protein interaction. , 2005, Current protein & peptide science.

[89]  A. Hamilton,et al.  Modulation of protein–protein interactions by synthetic receptors: Design of molecules that disrupt serine protease–proteinaceous inhibitor interaction , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[90]  K. Brown,et al.  Techniques: the application of accelerator mass spectrometry to pharmacology and toxicology. , 2004, Trends in pharmacological sciences.

[91]  W. Lambert,et al.  Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid , 2003, Journal of the American Society for Mass Spectrometry.

[92]  M. Borsaru,et al.  Neutron activation analysis , 1972 .

[93]  S. Srinivasula,et al.  Mechanism of XIAP-mediated inhibition of caspase-9. , 2003, Molecular cell.

[94]  M. Millot.  Separation of drug enantiomers by liquid chromatography and capillary electrophoresis, using immobilized proteins as chiral selectors. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[95]  Julie McMurry,et al.  Immuno‐informatics: Mining genomes for vaccine components , 2002, Immunology and cell biology.

[96]  R. Meadows,et al.  X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death , 1996, Nature.

[97]  Walter A. Korfmacher,et al.  Simultaneous determination of a drug candidate and its metabolite in rat plasma samples using ultrafast monolithic column high-performance liquid chromatography/tandem mass spectrometry. , 2002, Rapid communications in mass spectrometry : RCM.

[98]  A. Leach.  Molecular Modelling: Principles and Applications , 1996 .

[99]  T. H. Mclean,et al.  Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling. , 2005, Journal of medicinal chemistry.

[100]  S. Sebti,et al.  Terphenyl-based helical mimetics that disrupt the p53/HDM2 interaction. , 2005, Angewandte Chemie.

[101]  S. Fields,et al.  A novel genetic system to detect protein–protein interactions , 1989, Nature.

[102]  J. Sherma,et al.  Development and validation of a high-performance thin-layer chromatographic method with densitometric detection for determination of bisacodyl in pharmaceutical tablets , 2003 .

[103]  Paul W Erhardt.  A human drug metabolism database: potential roles in the quantitative predictions of drug metabolism and metabolism-related drug-drug interactions. , 2003, Current drug metabolism.

[104]  M. Jemal,et al.  Liquid chromatography-tandem mass spectrometric quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human peripheral blood mononuclear cells (PBMC): practical approaches to PBMC preparation and PBMC assay design for high-throughput analysis. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[105]  D. Wu,et al.  High throughput liquid chromatography/mass spectrometry bioanalysis using 96-well disk solid phase extraction plate for the sample preparation. , 1998, Rapid communications in mass spectrometry : RCM.

[106]  K. Imai,et al.  Monoclonal antibodies as effective therapeutic agents for solid tumors , 2004, Cancer science.

[107]  G. Scriba.  Selected fundamental aspects of chiral electromigration techniques and their application to pharmaceutical and biomedical analysis. , 2002, Journal of pharmaceutical and biomedical analysis.

[108]  A E Howard,et al.  An analysis of current methodologies for conformational searching of complex molecules. , 1988, Journal of medicinal chemistry.

[109]  Neha S. Gandhi,et al.  3D QSAR studies of N-4-arylacryloylpiperazin-1-yl-phenyl-oxazolidinones: a novel class of antibacterial agents. , 2006, Bioorganic & Medicinal Chemistry Letters.

[110]  M. Levitt,et al.  The complexity and accuracy of discrete state models of protein structure. , 1995, Journal of molecular biology.

[111]  Hans-Joachim Böhm,et al.  The computer program LUDI: A new method for the de novo design of enzyme inhibitors , 1992, J. Comput. Aided Mol. Des..

[112]  Steven Fletcher,et al.  Protein surface recognition and proteomimetics: mimics of protein surface structure and function. , 2005, Current opinion in chemical biology.

[113]  J. Veuthey,et al.  Column-Switching Procedures for the Fast Analysis of Drugs in Biologic Samples , 2004, Therapeutic drug monitoring.

[114]  M. Murcko,et al.  GroupBuild: a fragment-based method for de novo drug design. , 1993, Journal of medicinal chemistry.

[115]  A. Rizzi.  Fundamental aspects of chiral separations by capillary electrophoresis , 2001, Electrophoresis.

[116]  W. M. Haynes.  CRC Handbook of Chemistry and Physics , 1990 .

[117]  Yuan-qing Xia,et al.  Ternary-column system for high-throughput direct-injection bioanalysis by liquid chromatography/tandem mass spectrometry. , 2000, Rapid communications in mass spectrometry : RCM.

[118]  James Robinson,et al.  IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex , 2003, Nucleic Acids Res..

[119]  C. Gaeta,et al.  Transglutaminase surface recognition by peptidocalix[4]arene diversomers , 2005 .

[120]  Gopi Shankar,et al.  Scientific and regulatory considerations on the immunogenicity of biologics. , 2006, Trends in biotechnology.

[121]  E. Sahai,et al.  RHO–GTPases and cancer , 2002, Nature Reviews Cancer.

[122]  Min Zhang,et al.  Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking. , 2006, Journal of medicinal chemistry.

[123]  David C. Van Essen,et al.  Windows on the brain: the emerging role of atlases and databases in neuroscience , 2002, Current Opinion in Neurobiology.

[124]  N. Jing,et al.  Targeting Stat3 in cancer therapy. , 2005, Anti-cancer drugs.

[125]  P. Dupont,et al.  Quantitative distribution studies in animals: cross-validation of radioluminography versus liquid-scintillation measurement. , 2000, Regulatory toxicology and pharmacology : RTP.

[126]  J. Matthews,et al.  Protein-protein interactions in human disease. , 2005, Current opinion in structural biology.

[127]  J. Kim,et al.  Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-atpases. , 2001, The Journal of pharmacology and experimental therapeutics.

[128]  T. Dragic,et al.  CD81 is an entry coreceptor for hepatitis C virus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[129]  M. Botchan,et al.  The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2. , 2004, Genes & development.

[130]  R. F. Tetzlaff,et al.  Validation of computerized liquid chromatographic systems , 1994 .

[131]  D. Chao,et al.  BCL-2 family: regulators of cell death. , 1998, Annual review of immunology.

[132]  J. Henion,et al.  Atmospheric pressure ionization LC/MS/MS techniques for drug disposition studies. , 1998, Journal of pharmaceutical sciences.

[133]  H R Hoogenboom,et al.  Antibody phage display technology and its applications. , 1998, Immunotechnology : an international journal of immunological engineering.

[134]  D. Hockenbery,et al.  Promises and challenges of targeting Bcl-2 anti-apoptotic proteins for cancer therapy. , 2004, Biochimica et biophysica acta.

[135]  M. De Meulder,et al.  Development and validation of a liquid chromatographic-tandem mass spectrometric method for the determination of galantamine in human heparinised plasma. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[136]  T. Baillie,et al.  Drug metabolites in safety testing. , 2002, Toxicology and applied pharmacology.

[137]  K. Allen,et al.  Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid , 2005, Annals of clinical biochemistry.

[138]  M. Hutta,et al.  Role of biological matrices during the analysis of chiral drugs by liquid chromatography. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[139]  A. Griffiths,et al.  Strategies for selection of antibodies by phage display. , 1998, Current opinion in biotechnology.

[140]  E. Dickson,et al.  Neutron-activation analysis: a novel method for the assay of iohexol. , 2003, The Journal of laboratory and clinical medicine.

[141]  J. R. Huth,et al.  Discovery of novel inhibitors of Bcl-xL using multiple high-throughput screening platforms. , 2004, Analytical biochemistry.

[142]  S. Korsmeyer,et al.  Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix , 2004, Science.

[143]  R. D'argy,et al.  Quantitative whole-body radioluminography-future strategy for balance and tissue distribution studies. , 2000, Regulatory toxicology and pharmacology : RTP.

[144]  W. Naidong,et al.  Analysis of omeprazole and 5-OH omeprazole in human plasma using hydrophilic interaction chromatography with tandem mass spectrometry (HILIC-MS/MS)--eliminating evaporation and reconstitution steps in 96-well liquid/liquid extraction. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[145]  H. Böhm,et al.  A novel computational tool for automated structure‐based drug design , 1993, Journal of molecular recognition : JMR.

[146]  Christian von Mering,et al.  STRING: a database of predicted functional associations between proteins , 2003, Nucleic Acids Res..

[147]  C. Lipinski.  Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[148]  R. Clement,et al.  Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of SCH 211803 in rat and monkey plasma using automated 96-well protein precipitation. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[149]  M. Doddareddy,et al.  Hologram quantitative structure activity relationship studies on 5-HT6 antagonists. , 2004, Bioorganic & medicinal chemistry.

[150]  N. Srinivas.  Simultaneous chiral analyses of multiple analytes: case studies, implications and method development considerations. , 2004, Biomedical chromatography : BMC.

[151]  R. Cortese,et al.  Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor* , 2003, Journal of Biological Chemistry.

[152]  Sherry Wang,et al.  Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. , 2007, Journal of pharmaceutical and biomedical analysis.

[153]  T. Olah,et al.  The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. , 1999, Rapid communications in mass spectrometry : RCM.

[154]  F. Tse,et al.  Liquid-liquid extraction using 96-well plate format in conjunction with liquid chromatography/tandem mass spectrometry for quantitative determination of methylphenidate (Ritalin) in human plasma. , 2000, Rapid communications in mass spectrometry : RCM.

[155]  Mike Tyers,et al.  The GRID: The General Repository for Interaction Datasets , 2003, Genome Biology.

[156]  G A Burns,et al.  Knowledge management of the neuroscientific literature: the data model and underlying strategy of the NeuroScholar system. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[157]  J. Visvader,et al.  Tandem LIM domains provide synergistic binding in the LMO4:Ldb1 complex , 2004, The EMBO journal.

[158]  Binodh DeSilva,et al.  Bioanalytical Method Validation for Macromolecules in Support of Pharmacokinetic Studies , 2005, Pharmaceutical Research.

[159]  Samuel H. Gellman,et al.  Rational Development of β-Peptide Inhibitors of Human Cytomegalovirus Entry* , 2006, Journal of Biological Chemistry.

[160]  M. Satia,et al.  High-performance thin-layer chromatographic method for the detection and determination of lansoprazole in human plasma and its use in pharmacokinetic studies. , 1997, Journal of Chromatography B: Biomedical Sciences and Applications.

[161]  Joseph Sneddon,et al.  A practical guide to graphite furnace atomic absorption spectrometry , 1998 .

[162]  Adriano D Andricopulo,et al.  Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators. , 2005, Bioorganic & medicinal chemistry letters.

[163]  J M Blaney,et al.  A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.

[164]  J. Adamovics.  Chromatographic Analysis of Pharmaceuticals , 1996 .

[165]  Perry L. Miller,et al.  The Human Brain Project: neuroinformatics tools for integrating, searching and modeling multidisciplinary neuroscience data , 1998, Trends in Neurosciences.

[166]  M. F. Silva,et al.  Metal content monitoring in Hypericum perforatum pharmaceutical derivatives by atomic absorption and emission spectrometry. , 2004, Journal of pharmaceutical and biomedical analysis.

[167]  J. T. Wu,et al.  High-speed liquid chromatography/tandem mass spectrometry using a monolithic column for high-throughput bioanalysis. , 2001, Rapid communications in mass spectrometry : RCM.

[168]  E. Jones,et al.  Anti-ovalbumin monoclonal antibodies interact with their antigen in internal membranes of Xenopus oocytes , 1982, Nature.

[169]  G. Vas,et al.  Solid-phase microextraction: a powerful sample preparation tool prior to mass spectrometric analysis. , 2004, Journal of mass spectrometry : JMS.

[170]  Wilson Z Shou,et al.  Liquid chromatography/tandem mass spectrometric bioanalysis using normal-phase columns with aqueous/organic mobile phases - a novel approach of eliminating evaporation and reconstitution steps in 96-well SPE. , 2002, Rapid communications in mass spectrometry : RCM.

[171]  Andrew D. Hamilton,et al.  Terphenyl-Based Bak BH3 α-Helical Proteomimetics as Low-Molecular-Weight Antagonists of Bcl-xL , 2005 .

[172]  Qiang Zhang,et al.  Discovery of novel triazole-based opioid receptor antagonists. , 2006, Journal of medicinal chemistry.

[173]  Paul A. Bartlett,et al.  CAVEAT: A program to facilitate the design of organic molecules , 1994, J. Comput. Aided Mol. Des..

[174]  H. Koh,et al.  Current trends in modern pharmaceutical analysis for drug discovery. , 2003, Drug discovery today.

[175]  R. Altmeyer.  Virus attachment and entry offer numerous targets for antiviral therapy. , 2004, Current pharmaceutical design.

[176]  Clemencia Pinilla,et al.  Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. , 2004, Cancer cell.

[177]  J. Baseman,et al.  The epidemiology of human papillomavirus infections. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[178]  J Pauwels,et al.  k0-NAA, a valuable tool for reference-material producers , 2001, Fresenius' journal of analytical chemistry.

[179]  H. Lingeman,et al.  Derivatization in capillary electrophoresis. , 1998, Journal of chromatography. A.

[180]  L. Vassilev,et al.  In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.

[181]  H. Cai,et al.  High-throughput high-performance liquid chromatography/mass spectrometry for modern drug discovery. , 2001, Current opinion in biotechnology.

[182]  B. Welz.  Atomic absorption spectrometry , 1985 .

[183]  George S. Hammond,et al.  A Correlation of Reaction Rates , 1955 .

[184]  B. Graves,et al.  Small molecule inhibitors of p53/MDM2 interaction. , 2005, Current topics in medicinal chemistry.

[185]  M. Lee,et al.  LC/MS applications in drug development. , 2002, Mass spectrometry reviews.

[186]  G. Tucker.  Integrins: Molecular targets in cancer therapy , 2006, Current oncology reports.

[187]  Fa-mei Li,et al.  Chemiluminescence detection in HPLC and CE for pharmaceutical and biomedical analysis. , 2003, Biomedical chromatography : BMC.

[188]  Yong Wang,et al.  Crystal Structure of the E2 Transactivation Domain of Human Papillomavirus Type 11 Bound to a Protein Interaction Inhibitor* , 2004, Journal of Biological Chemistry.

[189]  C. Parini,et al.  Novel bone antiresorptive agents that selectively inhibit the osteoclast V-H+-ATPase. , 2001, Farmaco.

[190]  Shaomeng Wang,et al.  Structure-based design of potent, conformationally constrained Smac mimetics. , 2004, Journal of the American Chemical Society.

[191]  A. Hopkins,et al.  Navigating chemical space for biology and medicine , 2004, Nature.

[192]  Martin Saunders,et al.  Stochastic search for the conformations of bicyclic hydrocarbons , 1989 .

[193]  S. Ahuja.  Derivatization in gas chromatography. , 1976, Journal of pharmaceutical sciences.

[194]  S. Haswell,et al.  Atomic absorption spectrometry: theory, design and applications. , 1991 .

[195]  Roland L. Dunbrack,et al.  Conformational analysis of the backbone-dependent rotamer preferences of protein sidechains , 1994, Nature Structural Biology.

[196]  G. Warren,et al.  Microinjection of mRNA coding for an anti-golgi antibody inhibits intracellular transport of a viral membrane protein , 1984, Cell.

[197]  O. Mekenyan,et al.  The COREPA approach to lead generation: an application to ACE-inhibitors , 1999 .

[198]  T. Clackson,et al.  Making antibody fragments using phage display libraries , 1991, Nature.

[199]  E. Alnemri,et al.  Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. , 2000, Cancer research.

[200]  R. Natesh,et al.  Crystal structure of the human angiotensin-converting enzyme–lisinopril complex , 2003, Nature.

[201]  K. Wanner,et al.  Methods and Principles in Medicinal Chemistry , 2007 .

[202]  James L. Little,et al.  Liquid chromatography-mass spectrometry/mass spectrometry method development for drug metabolism studies: Examining lipid matrix ionization effects in plasma. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[203]  H. Hausen.  Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.

[204]  H. Lingeman,et al.  Pre‐, on‐ and post‐column derivatization in capillary electrophoresis , 1997, Electrophoresis.

[205]  Tudor I. Oprea,et al.  Chemoinformatics in drug discovery , 2005 .

[206]  R. Meadows,et al.  Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis , 1997, Science.

[207]  S. Vancompernolle,et al.  Small molecule inhibition of hepatitis C virus E2 binding to CD81. , 2003, Virology.

[208]  Jeremy Kenseth,et al.  High-throughput multiplexed capillary electrophoresis in drug discovery. , 2004, Drug discovery today.

[209]  Shaomeng Wang,et al.  Chimeric (α/β + α)-Peptide Ligands for the BH3-Recognition Cleft of Bcl-xL: Critical Role of the Molecular Scaffold in Protein Surface Recognition , 2005 .

[210]  Eleanor J. Gardiner,et al.  Clique-detection algorithms for matching three-dimensional molecular structures. , 1997, Journal of molecular graphics & modelling.

[211]  M. Karelson,et al.  Quantum-Chemical Descriptors in QSAR/QSPR Studies. , 1996, Chemical reviews.

[212]  Hans-Jürgen Federsel,et al.  Asymmetry on large scale: the roadmap to stereoselective processes , 2005, Nature Reviews Drug Discovery.

[213]  Lemont B. Kier,et al.  A Shape Index from Molecular Graphs , 1985 .

[214]  W. Howe,et al.  Computer design of bioactive molecules: A method for receptor‐based de novo ligand design , 1991, Proteins.

[215]  M. Satia,et al.  Plasma analysis of celiprolol by HPTLC: a useful technique for pharmacokinetic studies. , 2001, Journal of AOAC International.

[216]  L. G. Davis,et al.  Basic methods in molecular biology , 1986 .

[217]  A. Petros,et al.  Structural biology of the Bcl-2 family of proteins. , 2004, Biochimica et biophysica acta.

[218]  A. Balaban.  Highly discriminating distance-based topological index , 1982 .

[219]  Joshua A. Kritzer,et al.  Helical β-Peptide Inhibitors of the p53-hDM2 Interaction , 2004 .

[220]  Eric Klinenberg.  Inside the Box , 2002 .

[221]  R. Doms,et al.  The entry of entry inhibitors: A fusion of science and medicine , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[222]  Hua Li,et al.  CoMFA, CoMSIA, and Molecular Hologram QSAR Studies of Novel Neuronal nAChRs Ligands-Open Ring Analogues of 3-Pyridyl Ether , 2005, J. Chem. Inf. Model..

[223]  Matthew Clark,et al.  Generalized Fragment-Substructure Based Property Prediction Method , 2005, J. Chem. Inf. Model..

[224]  T. McDonnell,et al.  Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma , 2003, Oncogene.

[225]  N. Danielson,et al.  Pre- and postcolumn derivatization chemistry in conjunction with HPLC for pharmaceutical analysis. , 1988, Journal of chromatographic science.

[226]  Vinod P. Shah,et al.  Bioanalytical Method Validation—A Revisit with a Decade of Progress , 2000, Pharmaceutical Research.

[227]  James L. Little,et al.  Artifacts in trimethylsilyl derivatization reactions and ways to avoid them. , 1999, Journal of chromatography. A.

[228]  Jaroslaw Polanski,et al.  The Comparative Molecular Surface Analysis (COMSA): A Novel Tool for Molecular Design , 2000, Comput. Chem..

[229]  J. Haginaka.  Pharmaceutical and biomedical applications of enantioseparations using liquid chromatographic techniques. , 2002, Journal of pharmaceutical and biomedical analysis.

[230]  N. Rajurkar,et al.  Analysis of some herbal plants from India used in the control of diabetes mellitus by NAA and AAS techniques. , 1997, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[231]  Thomas R Gadek,et al.  Strategies and methods in the identification of antagonists of protein-protein interactions. , 2003, BioTechniques.

[232]  A. Shalaby,et al.  Spectrophotometric and AAS determination of ramipril and enalapril through ternary complex formation. , 2002, Journal of pharmaceutical and biomedical analysis.

[233]  Marie-Paule Lefranc,et al.  IMGT, the international ImMunoGeneTics database , 2001, Nucleic Acids Res..

[234]  David J Newman,et al.  Natural products as sources of new drugs over the period 1981-2002. , 2003, Journal of natural products.

[235]  W. Roth,et al.  Fully automated high-performance liquid chromatography. A new chromatograph for pharmacokinetic drug monitoring by direct injection of body fluids. , 1981, Journal of chromatography.

[236]  M. Randic.  Characterization of molecular branching , 1975 .

[237]  G M Pearl,et al.  Integration of computational analysis as a sentinel tool in toxicological assessments. , 2001, Current topics in medicinal chemistry.

[238]  Determination of the in vivo pharmacokinetics of palladium-bacteriopheophorbide (WST09) in EMT6 tumour-bearing Balb/c mice using graphite furnace atomic absorption spectroscopy. , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[239]  M D Barratt,et al.  The computational prediction of toxicity. , 2001, Current opinion in chemical biology.

[240]  S M Hubbard,et al.  The Cancer Informatics Infrastructure: a new initiative of the National Cancer Institute. , 2001, Seminars in oncology nursing.

[241]  J. Dědina,et al.  Hydride Generation Atomic Absorption Spectrometry , 1995 .

[242]  A. Petros,et al.  Rationale for Bcl‐XL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies , 2000, Protein science : a publication of the Protein Society.

[243]  John L. Sullivan,et al.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.

[244]  John Aurie Dean,et al.  Instrumental methods of analysis , 1951 .

[245]  H Briem,et al.  Multiple-conformation and protonation-state representation in 4D-QSAR: the neurokinin-1 receptor system. , 2000, Journal of medicinal chemistry.

[246]  R. Gorter,et al.  Examination of the Cutaneous Absorption of Copper After the Use of Copper-Containing Ointments , 2004, American journal of therapeutics.

[247]  Sui Yung Chan,et al.  Monitoring drug-protein interaction. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[248]  G. O’Connor,et al.  Development of a liquid chromatography-mass spectrometry method for the high-accuracy determination of creatinine in serum. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[249]  K D Altria,et al.  Overview of the status and applications of capillary electrophoresis to the analysis of small molecules. , 2004, Journal of chromatography. A.

[250]  Valerie J. Gillet,et al.  SPROUT: A program for structure generation , 1993, J. Comput. Aided Mol. Des..

[251]  Z. Ouyang,et al.  A strategy for a post-method-validation use of incurred biological samples for establishing the acceptability of a liquid chromatography/tandem mass-spectrometric method for quantitation of drugs in biological samples. , 2002, Rapid communications in mass spectrometry : RCM.

[252]  Johann Gasteiger,et al.  A new model for calculating atomic charges in molecules , 1978 .

[253]  Shaomeng Wang,et al.  Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site. , 2004, Journal of medicinal chemistry.

[254]  T. Pinkerton,et al.  Characterization of internal surface reversed-phase silica supports for liquid chromatography. , 1985, Journal of chromatography.

[255]  Shridhar R. Gadre,et al.  Electrostatics of Atoms and Molecules , 2001 .

[256]  Tatiana Nikolskaya,et al.  Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach. , 2003, Journal of medicinal chemistry.

[257]  A. Cavalli,et al.  Linking CoMFA and protein homology models of enzyme-inhibitor interactions: an application to non-steroidal aromatase inhibitors. , 2000, Bioorganic & medicinal chemistry.

[258]  Louise Thauvette,et al.  Inhibition of Human Papillomavirus DNA Replication by Small Molecule Antagonists of the E1-E2 Protein Interaction* , 2003, Journal of Biological Chemistry.

[259]  Chi-Ying F. Huang,et al.  Identification of the Substrates and Interaction Proteins of Aurora Kinases from a Protein-Protein Interaction Model * S , 2004, Molecular & Cellular Proteomics.

[260]  Jerry Goodisman,et al.  Analysis of cytotoxicities of platinum compounds , 2005, Cancer Chemotherapy and Pharmacology.

[261]  Kenneth R Wehmeyer,et al.  Semi-automated liquid--liquid back-extraction in a 96-well format to decrease sample preparation time for the determination of dextromethorphan and dextrorphan in human plasma. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[262]  P. Taylor.  Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. , 2005, Clinical biochemistry.

[263]  P. Goodford.  A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[264]  S. Hammond,et al.  Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemia. , 2005, Leukemia research.

[265]  Chunsheng Yin,et al.  Holographic QSAR of selected esters. , 2004, Chemosphere.

[266]  Danail Bonchev,et al.  Information theoretic indices for characterization of chemical structures , 1983 .

[267]  Suzanne Cory,et al.  The Bcl-2 family: roles in cell survival and oncogenesis , 2003, Oncogene.

[268]  P. Sprague.  Automated chemical hypothesis generation and database searching with Catalyst , 1995 .

[269]  Jamie Goode,et al.  Immunoinformatics: Bioinformatic Strategies for Better Understanding of Immune Function , 2003 .

[270]  Scott Gustafson,et al.  caCORE: A common infrastructure for cancer informatics , 2003, Bioinform..

[271]  G. Klebe,et al.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.

[272]  A. Amini.  Recent developments in chiral capillary electrophoresis and applications of this technique to pharmaceutical and biomedical analysis , 2001, Electrophoresis.

[273]  H. Salem,et al.  Colourimetric and AAS determination of cephalosporins using Reineck's salt. , 2002, Journal of pharmaceutical and biomedical analysis.

[274]  Takeshi Fukushima,et al.  Recent progress in derivatization methods for LC and CE analysis. , 2003, Journal of pharmaceutical and biomedical analysis.

[275]  J. Buolamwini,et al.  Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors. , 2003, Journal of medicinal chemistry.

[276]  René Holm,et al.  Successful in silico predicting of intestinal lymphatic transfer. , 2004, International journal of pharmaceutics.

[277]  D. Dimitrov,et al.  Virus entry: molecular mechanisms and biomedical applications , 2004, Nature Reviews Microbiology.

[278]  J. Tai,et al.  Stability and cytotoxicity of gambogic acid and its derivative, gambogoic acid. , 2005, Biological & pharmaceutical bulletin.

[279]  Kam Y. J. Zhang,et al.  Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3 , 2001, Nature Cell Biology.

[280]  Hans-Joachim Böhm,et al.  The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure , 1994, J. Comput. Aided Mol. Des..

[281]  A. Petros,et al.  Solution structure of the antiapoptotic protein bcl-2 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[282]  J. Visvader,et al.  LIM‐domain‐binding protein 1: a multifunctional cofactor that interacts with diverse proteins , 2003, EMBO reports.

[283]  Bradley L Ackermann,et al.  Recent advances in use of LC/MS/MS for quantitative high-throughput bioanalytical support of drug discovery. , 2002, Current topics in medicinal chemistry.

[284]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[285]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[286]  Karen Brown,et al.  Applications of accelerator mass spectrometry for pharmacological and toxicological research. , 2006, Mass spectrometry reviews.

[287]  B D Silverman,et al.  Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition. , 1996, Journal of medicinal chemistry.

[288]  D. Morgan,et al.  Analysis of intracellular protein function by antibody injection. , 1988, Immunology today.

[289]  W. Zeng,et al.  A direct injection high-throughput liquid chromatography tandem mass spectrometry method for the determination of a new orally active alphavbeta3 antagonist in human urine and dialysate. , 2003, Rapid communications in mass spectrometry : RCM.

[290]  Reino Laatikainen,et al.  Comparing the Performance of FLUFF-BALL to SEAL-CoMFA with a Large Diverse Estrogen Data Set: From Relevant Superpositions to Solid Predictions , 2005, J. Chem. Inf. Model..

[291]  A. Lansdown,et al.  Silver absorption and antibacterial efficacy of silver dressings. , 2005, Journal of Wound Care.

[292]  H. Hosoya.  Topological Index. A Newly Proposed Quantity Characterizing the Topological Nature of Structural Isomers of Saturated Hydrocarbons , 1971 .

[293]  J. Jasper,et al.  Quantitative estimates of precision for molecular isotopic measurements. , 2001, Rapid communications in mass spectrometry : RCM.

[294]  L. Felder,et al.  Determination of ketoconazole in human plasma by high-performance liquid chromatography-tandem mass spectrometry. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[295]  T. Rabbitts,et al.  Intracellular antibodies and challenges facing their use as therapeutic agents. , 2003, Trends in molecular medicine.

[296]  F. J. Holler,et al.  Principles of Instrumental Analysis , 1973 .

[297]  B. Matuszewski,et al.  Determination of rofecoxib (MK-0966), a cyclooxygenase-2 inhibitor, in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[298]  E. Isacoff,et al.  Protein surface recognition by rational design: nanomolar ligands for potassium channels. , 2003, Journal of the American Chemical Society.

[299]  Guillermo Moyna,et al.  Shape signatures: a new approach to computer-aided ligand- and receptor-based drug design. , 2003, Journal of medicinal chemistry.

[300]  A. Hamilton,et al.  Tetrabiphenylporphyrin-based receptors for protein surfaces show sub-nanomolar affinity and enhance unfolding. , 2003, Bioorganic & medicinal chemistry letters.

[301]  Lemont B. Kier,et al.  New predictors for several ADME/Tox properties: Aqueous solubility, human oral absorption, and Ames genotoxicity using topological descriptors , 2004, Molecular Diversity.

[302]  William J Welsh,et al.  Shape Signatures: speeding up computer aided drug discovery. , 2006, Drug discovery today.

[303]  Marie-Paule Lefranc,et al.  IMGT-ONTOLOGY and IMGT databases, tools and Web resources for immunogenetics and immunoinformatics. , 2004, Molecular immunology.

[304]  Andrew R. Leach,et al.  An Introduction to Chemoinformatics , 2003 .

[305]  Jérôme Lane,et al.  IMGT®, the international ImMunoGeneTics information system® , 2004, Nucleic Acids Res..

[306]  G. Caron,et al.  A combined in silico strategy to describe the variation of some 3D molecular properties of beta-cyclodextrin due to the formation of inclusion complexes. , 2006, Journal of molecular graphics & modelling.

[307]  W. D. Ehmann,et al.  Radiochemistry and nuclear methods of analysis , 1991 .

[308]  Andreas Plückthun,et al.  In-vitro protein evolution by ribosome display and mRNA display. , 2004, Journal of immunological methods.

[309]  Luis E Sojo,et al.  Internal standard signal suppression by co-eluting analyte in isotope dilution LC-ESI-MS. , 2003, The Analyst.

[310]  W. Shou,et al.  Development and validation of a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of ribavirin in human plasma and serum. , 2002, Journal of pharmaceutical and biomedical analysis.

[311]  G. Subbaraju,et al.  Estimation of trans-resveratrol in herbal extracts and dosage forms by high-performance thin-layer chromatography. , 2005, Chemical & pharmaceutical bulletin.

[312]  Daisuke Kihara,et al.  Bioinformatics resources for cancer research with an emphasis on gene function and structure prediction tools , 2006, Cancer informatics.

[313]  Bernard Chazelle,et al.  Matching 3D models with shape distributions , 2001, Proceedings International Conference on Shape Modeling and Applications.